[New triple therapy in chronic hepatitis C. Increased patient chances].
作者信息
Stiefelhagen Peter
出版信息
MMW Fortschr Med. 2011 Sep 29;153(39):20.
PMID:21991830
Abstract
摘要
相似文献
1
[New triple therapy in chronic hepatitis C. Increased patient chances].[慢性丙型肝炎的新三联疗法。增加患者治愈几率]
MMW Fortschr Med. 2011 Sep 29;153(39):20.
2
Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.慢性丙型肝炎病毒基因型 1 感染经治患者的处理方法。
Infect Dis Clin North Am. 2012 Dec;26(4):903-15. doi: 10.1016/j.idc.2012.08.008.
3
[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].丙型肝炎治疗的新时代：“现在治疗可以个体化了”（医学博士德克·艾内克访谈）
MMW Fortschr Med. 2011 Jul 21;153(29-31):17.
4
Future perspectives: towards interferon-free regimens for HCV.未来展望：迈向丙型肝炎病毒无干扰素治疗方案
Antivir Ther. 2012;17(6 Pt B):1201-10. doi: 10.3851/IMP2431. Epub 2012 Oct 5.
5
Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care.蛋白酶抑制剂治疗慢性丙型肝炎基因型 1 感染：新的治疗标准。
Lancet Infect Dis. 2012 Sep;12(9):717-28. doi: 10.1016/S1473-3099(12)70060-9. Epub 2012 May 29.
6
[Treatment of hepatitis C infection. A revolution should not hide another].[丙型肝炎感染的治疗。一场革命不应掩盖另一场革命]
Presse Med. 2014 Apr;43(4 Pt 1):339-40. doi: 10.1016/j.lpm.2013.12.009. Epub 2014 Mar 21.
7
[Conclusions].[结论]。
Enferm Infecc Microbiol Clin. 2013 Jul;31 Suppl 3:49-50. doi: 10.1016/S0213-005X(13)70124-1.
8
[Studies with boceprevir].[博赛泼维的研究]
MMW Fortschr Med. 2011 Jul 21;153(29-31):16.
9
[Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].[从剂量和给药方法方面探讨干扰素对慢性丙型肝炎的治疗效果]
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):493-6.
10
First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients.用于丙型肝炎基因1型治疗的第一代蛋白酶抑制剂：巴西患者的真实治疗经验。
Rev Soc Bras Med Trop. 2018 Mar-Apr;51(2):146-154. doi: 10.1590/0037-8682-0153-2017.
Zotero 插件